129 related articles for article (PubMed ID: 25282877)
21. [Applications of platelets in studies on traditional Chinese medicines promoting blood circulation to remove blood stasis].
Wang FQ; Chen C; Xia ZN; Yang FQ
Zhongguo Zhong Yao Za Zhi; 2014 Aug; 39(16):2993-3003. PubMed ID: 25509277
[TBL] [Abstract][Full Text] [Related]
22. Silencing of vanilloid receptor TRPV1 by RNAi reduces neuropathic and visceral pain in vivo.
Christoph T; Grünweller A; Mika J; Schäfer MK; Wade EJ; Weihe E; Erdmann VA; Frank R; Gillen C; Kurreck J
Biochem Biophys Res Commun; 2006 Nov; 350(1):238-43. PubMed ID: 16996476
[TBL] [Abstract][Full Text] [Related]
23. Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade.
Gavva NR; Bannon AW; Hovland DN; Lehto SG; Klionsky L; Surapaneni S; Immke DC; Henley C; Arik L; Bak A; Davis J; Ernst N; Hever G; Kuang R; Shi L; Tamir R; Wang J; Wang W; Zajic G; Zhu D; Norman MH; Louis JC; Magal E; Treanor JJ
J Pharmacol Exp Ther; 2007 Oct; 323(1):128-37. PubMed ID: 17652633
[TBL] [Abstract][Full Text] [Related]
24. TRPV1b overexpression negatively regulates TRPV1 responsiveness to capsaicin, heat and low pH in HEK293 cells.
Vos MH; Neelands TR; McDonald HA; Choi W; Kroeger PE; Puttfarcken PS; Faltynek CR; Moreland RB; Han P
J Neurochem; 2006 Nov; 99(4):1088-102. PubMed ID: 17018028
[TBL] [Abstract][Full Text] [Related]
25. Transcription of the pain-related TRPV1 gene requires Runx1 and C/EBPβ factors.
Ugarte GD; Diaz E; Biscaia M; Stehberg J; Montecino M; van Zundert B
J Cell Physiol; 2013 Apr; 228(4):860-70. PubMed ID: 23018770
[TBL] [Abstract][Full Text] [Related]
26. Hot receptors in the brain.
Steenland HW; Ko SW; Wu LJ; Zhuo M
Mol Pain; 2006 Nov; 2():34. PubMed ID: 17092351
[TBL] [Abstract][Full Text] [Related]
27. Old molecules for new receptors: Trp(Nps) dipeptide derivatives as vanilloid TRPV1 channel blockers.
Bonache MA; García-Martínez C; García de Diego L; Carreño C; Pérez de Vega MJ; García-López MT; Ferrer-Montiel A; González-Muñiz R
ChemMedChem; 2006 Apr; 1(4):429-38. PubMed ID: 16892378
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of cochinchinenin B on capsaicin-activated responses in rat dorsal root ganglion neurons.
Wang ST; Chen S; Guo M; Liu XM
Brain Res; 2008 Mar; 1201():34-40. PubMed ID: 18294619
[TBL] [Abstract][Full Text] [Related]
29. Targeting TRPV1 for pain relief: limits, losers and laurels.
Szallasi A; Sheta M
Expert Opin Investig Drugs; 2012 Sep; 21(9):1351-69. PubMed ID: 22780443
[TBL] [Abstract][Full Text] [Related]
30. [Controlled clinical trials of therapeutic effects of Chinese herbs promoting blood circulation and removing blood stasis on the treatment of reflex sympathetic dystrophy with type of stagnation of vital energy and blood stasis].
Xu RS; Zong XH; Li XG
Zhongguo Gu Shang; 2009 Dec; 22(12):920-2. PubMed ID: 20112576
[TBL] [Abstract][Full Text] [Related]
31. The analgesic drug, tramadol, acts as an agonist of the transient receptor potential vanilloid-1.
Marincsák R; Tóth BI; Czifra G; Szabó T; Kovács L; Bíró T
Anesth Analg; 2008 Jun; 106(6):1890-6. PubMed ID: 18499628
[TBL] [Abstract][Full Text] [Related]
32. [Analysis on composition and medication regularities of prescriptions treating hypochondriac pain based on traditional Chinese medicine inheritance support system inheritance support platform].
Zhao YQ; Teng J
Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(6):1203-6. PubMed ID: 26226771
[TBL] [Abstract][Full Text] [Related]
33. Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain.
Endres-Becker J; Heppenstall PA; Mousa SA; Labuz D; Oksche A; Schäfer M; Stein C; Zöllner C
Mol Pharmacol; 2007 Jan; 71(1):12-8. PubMed ID: 17005903
[TBL] [Abstract][Full Text] [Related]
34. The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans.
Chizh BA; O'Donnell MB; Napolitano A; Wang J; Brooke AC; Aylott MC; Bullman JN; Gray EJ; Lai RY; Williams PM; Appleby JM
Pain; 2007 Nov; 132(1-2):132-41. PubMed ID: 17659837
[TBL] [Abstract][Full Text] [Related]
35. Disease-related changes in TRPV1 expression and its implications for drug development.
Premkumar LS; Bishnoi M
Curr Top Med Chem; 2011; 11(17):2192-209. PubMed ID: 21671875
[TBL] [Abstract][Full Text] [Related]
36. Involvement of TRPV1 in nociceptive behavior in a rat model of cancer pain.
Shinoda M; Ogino A; Ozaki N; Urano H; Hironaka K; Yasui M; Sugiura Y
J Pain; 2008 Aug; 9(8):687-99. PubMed ID: 18455478
[TBL] [Abstract][Full Text] [Related]
37. Bone cancer increases transient receptor potential vanilloid subfamily 1 expression within distinct subpopulations of dorsal root ganglion neurons.
Niiyama Y; Kawamata T; Yamamoto J; Omote K; Namiki A
Neuroscience; 2007 Aug; 148(2):560-72. PubMed ID: 17656027
[TBL] [Abstract][Full Text] [Related]
38. Activation of the transient receptor potential vanilloid-1 (TRPV1) channel opens the gate for pain relief.
Jancsó G; Dux M; Oszlács O; Sántha P
Br J Pharmacol; 2008 Dec; 155(8):1139-41. PubMed ID: 18997813
[TBL] [Abstract][Full Text] [Related]
39. Design and synthesis of peripherally restricted transient receptor potential vanilloid 1 (TRPV1) antagonists.
Tamayo N; Liao H; Stec MM; Wang X; Chakrabarti P; Retz D; Doherty EM; Surapaneni S; Tamir R; Bannon AW; Gavva NR; Norman MH
J Med Chem; 2008 May; 51(9):2744-57. PubMed ID: 18386885
[TBL] [Abstract][Full Text] [Related]
40. Modulation of the TRPV1 channel: current clinical trials and recent patents with focus on neurological conditions.
De Petrocellis L; Moriello AS
Recent Pat CNS Drug Discov; 2013 Dec; 8(3):180-204. PubMed ID: 24330123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
